Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-05 4:15 pm Purchase | 13G | Ambrx Biopharma Inc. AMAM | WuXi PharmaTech Healthcare Fund I L.P. | 1,000,000 1.600% | 1,000,000 (New Position) | View |
2022-02-08 4:01 pm Purchase | 13G | AMBRX BIOPHARMA INC AMAM | WuXi PharmaTech Healthcare Fund I L.P. | 29,267,687 12.000% | 29,267,687 (New Position) | View |
2022-01-26 06:09 am Purchase | 13G | ADAGENE INC ADS ADAG | WuXi PharmaTech Healthcare Fund I L.P. | 5,282,120 9.670% | 5,282,120 (New Position) | View |
2021-01-08 4:49 pm Purchase | 13G | UNITY BIOTECHNOLOGY INC NE UBX | WuXi PharmaTech Healthcare Fund I L.P. | 1,477,987 2.800% | 1,477,987 (New Position) | View |